Carol L. Greene

4.4k total citations · 3 hit papers
63 papers, 2.2k citations indexed

About

Carol L. Greene is a scholar working on Clinical Biochemistry, Molecular Biology and Genetics. According to data from OpenAlex, Carol L. Greene has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Clinical Biochemistry, 25 papers in Molecular Biology and 17 papers in Genetics. Recurrent topics in Carol L. Greene's work include Metabolism and Genetic Disorders (27 papers), Diet and metabolism studies (7 papers) and Mitochondrial Function and Pathology (6 papers). Carol L. Greene is often cited by papers focused on Metabolism and Genetic Disorders (27 papers), Diet and metabolism studies (7 papers) and Mitochondrial Function and Pathology (6 papers). Carol L. Greene collaborates with scholars based in United States, Canada and Cameroon. Carol L. Greene's co-authors include Sandra K. Fernbach, Beth W. Alderman, Katharine Bisordi, Lynn M. Schriml, Cynthia F. Bearer, Richard Lichenstein, James B. Munro, Victor Felix, Nicole Campion and Michelle Giglio and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and PEDIATRICS.

In The Last Decade

Carol L. Greene

61 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society

2014 372 citations Sumit Parikh, Amy Goldstein et al. Genetics in Medicine profile →
Human Disease Ontology 2018 update: classification, content and workflow expansion

2018 289 citations Lynn M. Schriml, James B. Munro et al. Nucleic Acids Research profile →
The Human Disease Ontology 2022 update

2021 164 citations Lynn M. Schriml, James B. Munro et al. Nucleic Acids Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol L. Greene United States	24	1.3k	885	443	329	308	63	2.2k
Peter M. van Hasselt Netherlands	31	1.2k 0.9×	562 0.6×	467 1.1×	234 0.7×	662 2.1×	114	2.5k
Eileen P. Treacy Ireland	31	1.2k 0.9×	1.4k 1.6×	400 0.9×	395 1.2×	522 1.7×	102	2.6k
Georgirene D. Vladutiu United States	24	1.4k 1.1×	679 0.8×	194 0.4×	143 0.4×	360 1.2×	82	2.5k
Jean‐Marc Nuoffer Switzerland	26	934 0.7×	518 0.6×	164 0.4×	171 0.5×	274 0.9×	112	2.0k
C. Charpentier France	26	1.2k 0.9×	1.0k 1.2×	148 0.3×	254 0.8×	285 0.9×	85	2.3k
Martin Lindner Germany	30	1.9k 1.5×	2.5k 2.8×	471 1.1×	909 2.8×	597 1.9×	76	3.4k
Soumeya Bekri France	29	1.2k 0.9×	293 0.3×	258 0.6×	310 0.9×	788 2.6×	124	3.4k
G. E. Lang Germany	10	1.2k 0.9×	578 0.7×	215 0.5×	69 0.2×	240 0.8×	25	5.2k
Joe T.R. Clarke Canada	32	1.1k 0.9×	537 0.6×	210 0.5×	206 0.6×	1.5k 4.8×	109	2.8k
Flemming Güttler Denmark	24	1.4k 1.1×	1.7k 1.9×	240 0.5×	296 0.9×	568 1.8×	58	2.3k

Countries citing papers authored by Carol L. Greene

Since Specialization

Citations

This map shows the geographic impact of Carol L. Greene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol L. Greene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol L. Greene more than expected).

Fields of papers citing papers by Carol L. Greene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol L. Greene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol L. Greene. The network helps show where Carol L. Greene may publish in the future.

Co-authorship network of co-authors of Carol L. Greene

This figure shows the co-authorship network connecting the top 25 collaborators of Carol L. Greene. A scholar is included among the top collaborators of Carol L. Greene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol L. Greene. Carol L. Greene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schriml, Lynn M., Richard Lichenstein, Katharine Bisordi, et al.. (2023). Modeling the enigma of complex disease etiology. Journal of Translational Medicine. 21(1). 148–148. 6 indexed citations

Baron, J. Allen, Dustin Olley, Victor Felix, et al.. (2023). The DO-KB Knowledgebase: a 20-year journey developing the disease open science ecosystem. Nucleic Acids Research. 52(D1). D1305–D1314. 25 indexed citations

Greene, Carol L., et al.. (2020). What Factors Influence Motivation for Graduate Education. 11(1). 21–37. 1 indexed citations

Lubin, Ira M., et al.. (2019). Challenges and opportunities for integrating genetic testing into a diagnostic workflow: heritable long QT syndrome as a model. Diagnosis. 8(1). 17–26.

Greene, Carol L., Erin T. Strovel, Elaine Spector, et al.. (2016). The M405V allele of the glutaryl-CoA dehydrogenase gene is an important marker for glutaric aciduria type I (GA-I) low excretors. Molecular Genetics and Metabolism. 119(1-2). 50–56. 11 indexed citations

Parikh, Sumit, Amy Goldstein, Mary Kay Koenig, et al.. (2014). Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genetics in Medicine. 17(9). 689–701. 372 indexed citations breakdown →

Schmidt, Johanna, Saltanat Childress, Natasha Bonhomme, et al.. (2012). The impact of false-positive newborn screening results on families: a qualitative study. Genetics in Medicine. 14(1). 76–80. 75 indexed citations

Shippy, Richard, et al.. (2010). Microarray analysis of an unbalanced t(4;13) translocation narrows down the trisomy 13 associated polydactyly to a 7 Mb region. American Journal of Medical Genetics Part A. 152A(11). 2906–2907. 1 indexed citations

Greene, Carol L.. (2010). Storage, use of newborn screening samples raise complex issues. AAP News. 31(8). 16–16. 1 indexed citations

10.

Wolf, Barry, et al.. (2003). Markedly elevated serum biotinidase activity may indicate glycogen storage disease type Ia. Journal of Inherited Metabolic Disease. 26(8). 805–809. 10 indexed citations

11.

Greene, Carol L. & Michael J. Goodman. (2003). Neonatal Abstinence Syndrome: Strategies for Care of the Drug-Exposed Infant. Neonatal Network The Journal of Neonatal Nursing. 22(4). 15–24. 16 indexed citations

12.

Watson, Michael S. & Carol L. Greene. (2001). Points to Consider in Preventing Unfair Discrimination Based on Genetic Disease Risk: A Position Statement of the American College of Medical Genetics. Genetics in Medicine. 3(6). 436–437. 16 indexed citations

13.

Chamberlin, Margaret E., et al.. (2000). Methionine Adenosyltransferase I/III Deficiency: Novel Mutationsand Clinical Variations. The American Journal of Human Genetics. 66(2). 347–355. 58 indexed citations

14.

Gardner, James S., Pascal Boileau, Beth W. Alderman, et al.. (1998). Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis. International Journal of Epidemiology. 27(1). 64–67. 66 indexed citations

15.

Alderman, Beth W., Cynthia M. Bradley, Carol L. Greene, Sandra K. Fernbach, & Anna E. Barón. (1994). Increased risk of craniosynostosis with maternal cigarette smoking during pregnancy. Teratology. 50(1). 13–18. 52 indexed citations

16.

Arnold, Georgianne L., et al.. (1993). Molybdenum cofactor deficiency. The Journal of Pediatrics. 123(4). 595–598. 27 indexed citations

17.

Luder, Anthony, et al.. (1992). Hyperuricemia in medium-chain acyl-coenzyme A dehydrogenase deficiency. The Journal of Pediatrics. 120(3). 444–446. 7 indexed citations

18.

Luder, Anthony & Carol L. Greene. (1989). Maternal phenylketonuria and hyperphenylalaninemia: Implications for medical practice in the United States. American Journal of Obstetrics and Gynecology. 161(5). 1102–1105. 14 indexed citations

19.

Amendt, Brad A., et al.. (1987). Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients.. Journal of Clinical Investigation. 79(5). 1303–1309. 133 indexed citations

20.

Gibson, K. Michael, et al.. (1982). 3-Hydroxy-3-methylglutaric aciduria: a new assay of 3-hydroxy-3-methylglutaryl-CoA lyase using high performance liquid chromatography. Clinica Chimica Acta. 126(2). 171–181. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact